These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 19422152)
1. Adalimumab: new indication. A last resort for treating plaque psoriasis: just another TNF alpha antagonist. Prescrire Int; 2008 Dec; 17(98):240. PubMed ID: 19422152 [No Abstract] [Full Text] [Related]
2. Adalimumab: new indication. Severe Crohn's disease: a second TNF alpha antagonist, subcutaneous administration. Prescrire Int; 2008 Aug; 17(96):137. PubMed ID: 19480092 [No Abstract] [Full Text] [Related]
3. Abatacept: new drug. Rheumatoid arthritis: after failure of TNF alpha antagonists and rituximab. Prescrire Int; 2008 Dec; 17(98):232. PubMed ID: 19422143 [No Abstract] [Full Text] [Related]
4. Developments in systemic immunomodulatory therapy for psoriasis. Berger EM; Gottlieb AB Curr Opin Pharmacol; 2007 Aug; 7(4):434-44. PubMed ID: 17627886 [TBL] [Abstract][Full Text] [Related]
6. Review and expert opinion on prevention and treatment of infliximab-related infusion reactions. Lecluse LL; Piskin G; Mekkes JR; Bos JD; de Rie MA Br J Dermatol; 2008 Sep; 159(3):527-36. PubMed ID: 18627374 [TBL] [Abstract][Full Text] [Related]
7. Infliximab: new indication. Severe Crohn's disease in children: many unknowns. Prescrire Int; 2008 Aug; 17(96):145. PubMed ID: 19489184 [TBL] [Abstract][Full Text] [Related]
8. Sustained effects of low dose infliximab in combination with methotrexate in the management of chronic recalcitrant psoriasis. Zargari O Dermatol Online J; 2005 Dec; 11(3):21. PubMed ID: 16409917 [TBL] [Abstract][Full Text] [Related]
9. [Therapy of chronic inflammatory bowel diseases. TNF-alpha blocker in Crohn disease: earlier use is rewarding]. MMW Fortschr Med; 2008 Dec; 150(51-52):54-5. PubMed ID: 19156959 [No Abstract] [Full Text] [Related]
10. Using 'number needed to treat' to express the magnitudes of benefit of ultraviolet B phototherapy and of antitumour necrosis factor-alpha therapies for psoriasis. Dawe RS Br J Dermatol; 2010 Feb; 162(2):456-7. PubMed ID: 19919632 [No Abstract] [Full Text] [Related]
11. [The experience of anti-TNF-alpha registries and observatories]. Sibilia J; Solignac M Ann Dermatol Venereol; 2010 Apr; 137(4 Suppl):18-21. PubMed ID: 20510167 [No Abstract] [Full Text] [Related]
13. New biologics for psoriasis and psoriatic arthritis. Rozenblit M; Lebwohl M Dermatol Ther; 2009; 22(1):56-60. PubMed ID: 19222517 [TBL] [Abstract][Full Text] [Related]
14. Adalimumab in the management of palmoplantar psoriasis. Ghate JV; Alspaugh CD J Drugs Dermatol; 2009 Dec; 8(12):1136-9. PubMed ID: 20027943 [TBL] [Abstract][Full Text] [Related]